Diminishing impact for weight loss users and reduction spend trails off after 6 months, but the shift in what they buy has evolved
"All of these things go together, and our goal is not only to make people smaller but also to make people healthier and stronger, which is so powerful." As more people explore the use of GLP-1 medicines -- KFF said about a third of adults had heard a lot about the drugs -- it will be integral for providers to practice holistic patient engagement and chronic disease management with their patients
Alternative Treatment Options for Type 2 Diabetes Type 2 diabetes management in the UK follows a stepwise approach aligned with NICE guidelines (NG28), which emphasise individualised treatment based on patient characteristics, comorbidities, and treatment goals
Once a monthly option clears Phase 3, the convenience pitch shifts decisively toward whichever monthly drug has the best efficacy-to-tolerability ratio
Yes, restarting weight loss medications after discontinuation is a reasonable medical decision that should be discussed with your healthcare provider